Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for INFLUENZA VIRUS VACCINE
- Efficacy of Probiotics (LiveSpo Navax) in Preventing Respiratory Diseases in Children
- HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia
- Phase 3 Open-Label Controlled Trial of Convalescent Plasma in Early COVID-19 Infection
- Systems Biological Assessment of Statin Effect on Vaccine Responses
- AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma
- Combining Intratumoral Flu Vaccine and Systemic Pembrolizumab in Patients With Early pMMR Colorectal Cancer
- A Study to Learn Whether Respiratory Syncytial Virus (RSV) and Flu Vaccines Given Together as a Single Shot Work as Well as When Given Separately
- Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant Recipients
- JT001 (VV116) for the Treatment of COVID-19
- Phase 2 Study of the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine
- Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile
- Effects of Nasal-spraying LiveSpo Navax in Treatment of Influenza Virus in Children
- A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age
- Influenza Vaccine With Topical Imiquimod in Influenza Vaccine Non-responsive Children
- Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae
- Immunotherapy Combined With Radiation and Influenza Vaccine for Pancreatic Cancer.
- COVID-19 VaccinE Response in Rheumatology Patients
- Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma
- Feasibility of Randomizing Danish Citizens Aged 65-79 Years to High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in a Pragmatic Registry-Based Setting
- A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pre
- Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine
- Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study)
- First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV, in Healthy Adults
- An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older
- A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older
- Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults
- Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE
- An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions
- Sargramostim Use in COVID-19 to Recover Patient Health
- Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza.
- A Multicenter Study to Assess Response to Influenza Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab
- Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection?
- Intratumoral Influenza Vaccine for Early Colorectal Cancer
- Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults
- Influenza Vaccine in Lung Transplant Patients - Antibody
- Influenza Vaccine in Lung Transplant Patients - T Cells
- Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies
- Influenza Vaccine in Lung Transplant Patients - Seroprotection
- Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season
- Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia
- Efficacy and Safety of Sirolimus in COVID-19 Infection
- Hesperidin and Diosmin for Treatment of COVID-19
- Control of COVID-19 Outbreaks in Long Term Care
- Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment
- Favipiravir vs Hydroxychloroquine vs Control in COVID -19
- Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19
- BCG Vaccination to Protect Healthcare Workers Against COVID-19
- The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19
- Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination
- Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection
- Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness Patients
- B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
- Vaccination Efficacy With Metformin in Older Adults
- Study to Assess the Efficacy of Baloxavir Marboxil Versus Placebo to Reduce Onward Transmission of Influenza A or B in Households
- Flublok or Fluzone With Advax-CpG55.2 or AF03
- A Study to Evaluate the Antibody Response of Influenza Vaccination Following Concomitant Exposure to Bimekizumab in Healthy Subjects
- Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults
- A Phase 2, Double-blind Study to Evaluate Immunogenicity and Safety of Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult Volunteers
- Analysis of Antigen Specific B Cell Responses to Immunization With Influenza Virus Vaccine
- 2017 A/H7N9 IIV Revaccination
- FLUAD vs. FLUZONE HD Influenza Vaccine in Residents of Long Term Care
- Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza
- Influenza Vaccine Responses
- 2013/2017 H7N9 Prime-Boost Interval
- H5N1 With or Without Topical Aldara in Healthy Adults
- Impact of a Fourth Hexavalent Vaccine After Hematopoietic Stem Cell Transplantation
- Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4
- Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly
- Improved Novel VaccIne CombinaTion InflUenza Study
- The Immune Response to Influenza Vaccinations in Elderly Individuals
- MMF for HIV Reservoir Reduction
- Study of Biomarkers of Immune Activation Associated With Symptoms and Immune Responses After Influenza Vaccination in Adults
- Yellow Fever Vaccine on Statin/ Non Statin Subjects
- Study of Sting Challenge and Serological Responses to Jack Jumper Venom Immunotherapy With Inulin as Adjuvant (Jumpvax)
- Two Doses of Multimeric-001 (M-001) Followed by Two Doses of an Influenza A/H7N9 Vaccine
- H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology
- Trial of Perioperative Tadalafil and Influenza Vaccination in Cancer Patients Undergoing Major Surgical Resection of a Primary Abdominal Malignancy
- A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia
- Influenza Vaccine Feasibility Study in Children With Persistent Asthma
- Imiquimod and Influenza Vaccine for Immunocompromised Patients
- Evaluation of Dupilumab in Children With Uncontrolled Asthma
- H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses
- 2-week dc of MTX and Influenza Vaccination in RA
- Safety of Nasal Influenza Immunisation in Children With Asthma
- Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma
- Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation
- Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
- Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)
- MTX Discontinuation and Vaccine Response
- Immunogenicity and Safety of the Seasonal Flu Vaccine in Elderly and in SOT Recipients
- Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation
- A Pilot Study of the Safety, Tolerability, and Effectiveness of Halo
- H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
- The Effect of Influenza Vaccination on the Systemic Inflammatory Response and Myocardial Protection in Patients Undergoing Cardiac Surgery: a Randomized Controlled Trial
- Efficacy & Safety of Nasal Influenza Immunisation in Children
- A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis
- Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study
- Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination
- Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric Participants
- Phase II Study to Assess Safety & Immunogenicity of Multimeric-001 Influenza Vaccine, Followed by TIV
- Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients
- A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
- Banlangen Granules Anti-seasonal Influenza Study
- H7N9 Mix and Match With MF59 in Healthy Elderly Persons
- The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine
- Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics
- A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1
- Safety of Nasal Influenza Immunisation in Egg Allergic Children - The SNIFFLE 2 Study
- Intradermal Influenza Vaccine in the Young
- Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
- Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC FLU®Pre-filled Syringe Injection and 'GC FLU®Injection' Administration.
- The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults
- Efficacy of Ondansetron on Vomiting Due to Acute Gastroenteritis in Pediatric During Winter
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults
- Adolescent Vaccination in Pharmacies
- Influenza Vaccine To Prevent Adverse Vascular Events:Pilot
- H7N9 Mix and Match With AS03 and MF59 in Healthy Adults
- H7N9 Mix and Match With MF59 in Healthy Adults
- Self-Administered Nasal Influenza Feasibility Study
- Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)
- Immune Response To Intranasal Influenza Vaccination
- Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists
- Efficacy and Safety of Influenza Vaccine During Sarcoidosis
- Evaluating Immune Response to Seasonal FluMist in Healthy Adults
- Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season
- Safety Study of FluMist With and Without Ampligen
- H5N1 Vaccination With and Without AS03: Systems Biology Analysis
- Standard Dose Versus High-Dose Inactivated Flu Vaccine in Pediatric Solid Organ Transplant Patients
- Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot
- Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis Patients
- Intradermal Trivalent Influenza Vaccine With Imiquimod
- Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide
- The Effects of GLA on Human Volunteers
- Strategies for Enhancing Mucosal Immunity to Influenza Vaccine
- Safety Study of Single Administration Intravenous Treatment for Influenza
- Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine
- H5N1 Mix and Match With AS03
- H5N1 Mix and Match With MF59
- Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults
- Swine Flu (Influenza A H1N1) Follow on Vaccine Study
- Standard Versus High-Dose Trivalent Inactivated Flu Vaccine in Pediatric Acute Lymphoblastic Leukemia Patients
- Relenza® Sentinel Site Monitoring Program in Japan
- Auto-immunity in Lupus Patients After Influenza Vaccine
- A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine
- Efficacy Safety Study of Flu Vaccine in Immunodepression Patients
- Comparison of Different Methods for Reducing Pain From Influenza Vaccine Injections
- Rapid Evaluation of Seasonal Influenza Vaccine
- Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations
- Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia
- Sanofi H1N1 + TIV - Adults and Elderly
- Safety and Immunogenicity Study of Intramuscular CCS/C-adjuvanted Influenza Vaccine in Elderly
- Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59
- VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactiva
- Study of the Effect of Probiotics on Respiratory Morbidity After Influenza Vaccination of Elderly in Nursing Homes
- Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home
- Zanamivir Versus Trivalent Split Virus Influenza Vaccine
- Vaccine for Prevention of Bird Flu
- Oseltamivir Randomised Controlled Efficacy Trial
- Risk Reduction in Coronary Heart Disease
- Effect of the Interferon Alpha Citizen by Sub-Lingual Way on the Humoral Immunizing Answer
- A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children
- Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients
- Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults
- Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally
- Higher Dose Intradermal H5 Vaccine
- Safety Study of Avian Flu Vaccine
- Th1 Response to Influenza: Aging and Vaccine Efficacy
- Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in Adults
- Efficacy of Sambucol in the Treatment of Influenza
- Improving the Efficacy of Experimental Malaria Vaccine AMA1-C1/Alhydrogel® (Registered Trademark)
- Study To Evaluate the Safety of Bivalent Vaccine
- H5 Vaccine Alone or With Adjuvant in Healthy Adults
- Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines
- H5 Adult - Chiron Study of Bird Flu Vaccine
- Inactivated Influenza A/H5N1 Vaccine in the Elderly
- Influenza Vaccination and Oral Anticoagulant Therapy
- Influenza Vaccine in Lung Transplant Patients
- A/H5N1 Vaccine in Healthy Children Aged 2-9 Years
- Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults
- Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age
- Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2
- A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas
- A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas
- Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals
- A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy
Clinical trials list
click for details